EIR Xellia Pharmaceuticals USA Oct 2016

Nicholas Paulin FDA, Lindsey Schwierjohann FDA, Lauren Smith FDA, Lauren Howard FDA$595.00 - Available Now

FDA investigators audited the Xellia Pharmaceuticals USA - Bedford, OH, United States facility and issued inspectional observation (via FDA 483) on 13 Oct 2016.

Product details

  • Category:
  • Inspection end: 13 Oct 2016
  • Location: Bedford, United States
  • FEI: 3012279857
Add To Cart